Nascent and Catalent sign product-development agreement; Piramal to see top-line growth;

> Piramal Healthcare should see top-line growth as the fiscal year progresses, fueled in large part by its contract research and manufacturing services and over-the-counter products business. Article

> Nascent Biologics and Catalent Pharma Solutions have come together on an antibody development agreement to help advance Pritumumab in the treatment of brain cancers. Release

> Medical imaging contract research veteran Eric S. Perlman was selected as the new chief medical officer for ACR Image Metrix by the American College of Radiology. Release

> Brian Mooney was appointed by Theorem Clinical Research as its senior vice president of global clinical development. Release